Company · CIK 1438533
Travere Therapeutics, Inc.
| CIK | 1438533 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | CA |
| Business address | CA |
| Listed | TVTX (Nasdaq) |
| First annual or quarterly report | 2010-10-28 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-281194 | 2024-08-01 | 2026-05-07 | 6 | |
| 333-259311 | 2021-09-03 | 2023-03-01 | 5 | |
| 333-227182 | 2018-09-04 | 2021-02-12 | 8 | |
| 333-198648 | 2014-09-09 | 2015-03-19 | 4 | |
| 333-192936 | 2013-12-18 | 2014-01-13 | 4 | |
| 333-192364 | 2013-11-15 | 2013-12-06 | 3 |
Filings
32| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-07 | 424B5Shelf takedown | 333-281194 | 0001193125-26-211968 |
| 2026-05-05 | 424B5Shelf takedown | 333-281194 | 0001193125-26-206334 |
| 2024-11-08 | 424B5Shelf takedown | 333-281194 | 0001193125-24-254147 |
| 2024-11-07 | 424B5Shelf takedown | 333-281194 | 0001193125-24-253102 |
| 2024-10-31 | 424B5Shelf takedown | 333-281194 | 0001438533-24-000050 |
| 2024-08-01 | S-3ASRShelf registered | 333-281194 | 0001193125-24-191647 |
| 2023-03-01 | 424B5Shelf takedown | 333-259311 | 0001193125-23-056548 |
| 2023-02-27 | 424B5Shelf takedown | 333-259311 | 0001193125-23-050949 |
| 2022-03-09 | 424B5Shelf takedown | 333-259311 | 0001193125-22-070587 |
| 2022-03-08 | 424B5Shelf takedown | 333-259311 | 0001193125-22-068713 |
| 2021-09-03 | S-3ASRShelf registered | 333-259311 | 0001193125-21-265549 |
| 2021-02-12 | 424B5Shelf takedown | 333-227182 | 0001193125-21-041735 |
| 2021-02-10 | 424B5Shelf takedown | 333-227182 | 0001193125-21-036369 |
| 2020-06-09 | 424B5Shelf takedown | 333-227182 | 0001193125-20-164634 |
| 2020-06-08 | 424B5Shelf takedown | 333-227182 | 0001193125-20-163477 |
| 2020-02-24 | 424B5Shelf takedown | 333-227182 | 0001193125-20-046689 |
| 2018-09-06 | 424B5Shelf takedown | 333-227182 | 0001193125-18-268237 |
| 2018-09-04 | 424B5Shelf takedown | 333-227182 | 0001193125-18-266241 |
| 2018-09-04 | S-3ASRShelf registered | 333-227182 | 0001193125-18-266161 |
| 2015-03-19 | 424B5Shelf takedown | 333-198648 | 0001193125-15-098742 |
| 2015-03-16 | 424B5Shelf takedown | 333-198648 | 0001193125-15-094088 |
| 2015-03-13 | EFFECTDeclared effective | 333-198648 | 9999999995-15-000602 |
| 2014-09-09 | S-3Shelf registered | 333-198648 | 0001193805-14-001807 |
| 2014-01-13 | 424B1Final prospectus | 333-192936 | 0001571049-14-000092 |
| 2014-01-09 | EFFECTDeclared effective | 333-192936 | 9999999995-14-000084 |
| 2014-01-07 | S-1/AAmendment | 333-192936 | 0001571049-14-000062 |
| 2013-12-18 | S-1Registration filed | 333-192936 | 0001193805-13-002301 |
| 2013-12-06 | EFFECTDeclared effective | 333-192364 | 9999999995-13-003479 |
| 2013-12-05 | S-1/AAmendment | 333-192364 | 0001193805-13-002208 |
| 2013-11-15 | S-1Registration filed | 333-192364 | 0001193805-13-002115 |
| 2013-03-15 | DRSDraft made public | 377-00125 | 0001193805-13-000658 |
| 2008-08-27 | RWWithdrawn | 000-53293 | 0001225279-08-000088 |